163 related articles for article (PubMed ID: 30746857)
1. MicroRNA-365 promotes the contractile phenotype of venous smooth muscle cells and inhibits neointimal formation in rat vein grafts.
Cao BJ; Zhu L; Wang XW; Zou RJ; Lu ZQ
IUBMB Life; 2019 Jul; 71(7):908-916. PubMed ID: 30746857
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts.
Wang XW; He XJ; Lee KC; Huang C; Hu JB; Zhou R; Xiang XY; Feng B; Lu ZQ
Int J Cardiol; 2016 Apr; 208():79-86. PubMed ID: 26828387
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-Mediated Gene Transfer of microRNA-21 Sponge Inhibits Neointimal Hyperplasia in Rat Vein Grafts.
Wang XW; Zhang C; Lee KC; He XJ; Lu ZQ; Huang C; Wu QC
Int J Biol Sci; 2017; 13(10):1309-1319. PubMed ID: 29104497
[No Abstract] [Full Text] [Related]
4. MicroRNA-146a sponge therapy suppresses neointimal formation in rat vein grafts.
Cao BJ; Wang XW; Zhu L; Zou RJ; Lu ZQ
IUBMB Life; 2019 Jan; 71(1):125-133. PubMed ID: 30291803
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein.
Huang K; Bao H; Yan ZQ; Wang L; Zhang P; Yao QP; Shi Q; Chen XH; Wang KX; Shen BR; Qi YX; Jiang ZL
Cardiovasc Res; 2017 Apr; 113(5):488-497. PubMed ID: 28137944
[TBL] [Abstract][Full Text] [Related]
6. Dedicator of cytokinesis 2 silencing therapy inhibits neointima formation and improves blood flow in rat vein grafts.
Cao BJ; Wang XW; Zhu L; Zou RJ; Lu ZQ
J Mol Cell Cardiol; 2019 Mar; 128():134-144. PubMed ID: 30716327
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.
Tan J; Yang L; Liu C; Yan Z
Sci Rep; 2017 Apr; 7():46602. PubMed ID: 28429763
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
[TBL] [Abstract][Full Text] [Related]
10. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 3 is a negative regulator for neointimal hyperplasia of vein graft stenosis.
Xiang S; Liu J; Dong N; Shi J; Xiao Y; Wang Y; Hu X; Gong L; Wang W
J Vasc Res; 2014; 51(2):132-43. PubMed ID: 24685947
[TBL] [Abstract][Full Text] [Related]
13. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation.
Lee J; Lim S; Song BW; Cha MJ; Ham O; Lee SY; Lee C; Park JH; Bae Y; Seo HH; Seung M; Choi E; Hwang KC
J Cell Biochem; 2015 Apr; 116(4):598-608. PubMed ID: 25389122
[TBL] [Abstract][Full Text] [Related]
15. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
[TBL] [Abstract][Full Text] [Related]
16. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
[TBL] [Abstract][Full Text] [Related]
17. miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation.
McDonald RA; White KM; Wu J; Cooley BC; Robertson KE; Halliday CA; McClure JD; Francis S; Lu R; Kennedy S; George SJ; Wan S; van Rooij E; Baker AH
Eur Heart J; 2013 Jun; 34(22):1636-43. PubMed ID: 23530023
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 3 Therapy Attenuates Aging Expression, Oxidative Stress Parameters, and Neointimal Hyperplasia Formation in Vein Grafts.
Lu H; Sun L; Chen W; Zhou Y; Liu K; Chen J; Zhang Z; Zhang C; Tian H
Ann Vasc Surg; 2020 Apr; 64():303-317. PubMed ID: 31394214
[TBL] [Abstract][Full Text] [Related]
19. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
20. Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow.
Liu SQ
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2630-9. PubMed ID: 10559005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
